Active Ingredient(s):Deflazacort FDA Approved: * February 9, 2017 Pharm Company: *MARATHON PHARMACEUTICALS LLC Category:Anti-Inflammatory
Deflazacort (trade name Calcort among others) is a glucocorticoid used as an anti-inflammatory and immunomodulatory agent.
It was patented in 1965 and approved for medical use in 1985. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication for Duchenne Muscular Dystrophy.
1 Medical uses
2 Adverse effects
3.1 Mechanism of action
3.2 Relative potency
6 External links
* May have multiple approval dates, manufacturers, or labelers.